The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials

Immunochemoradiotherapy for Patients with Oral Squamous Cell Carcinoma: Augmentation of OK-432-Induced Helper T Cell 1 Response by 5-FU and X-ray Irradiation

(2015) Tomoyuki Tano et al.   NEOPLASIA

Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer

(2014) S. Koido et al.   CLINICAL CANCER RESEARCH

Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen

(2014) Hisashi Wada et al.   JOURNAL OF IMMUNOTHERAPY

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer

(2014) Masanori Kobayashi et al.   Journal of Ovarian Research

Overcoming regulatory T-cell suppression by a lyophilized preparation ofStreptococcus pyogenes

(2013) Michiko Hirayama et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Trial Watch

(2013) Erika Vacchelli et al.   OncoImmunology

Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide

(2012) Shingo Eikawa et al.   INTERNATIONAL JOURNAL OF CANCER

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

(2012) Aimery de Gramont et al.   LANCET ONCOLOGY

Intrapleural Chemo- and Hyperthermotherapies for Malignant Pleural Effusion: A Randomized Prospective Study

(2011) Wen-Jun Chen et al.   CANCER INVESTIGATION

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

(2011) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I trial of preoperative intratumoral injection of immature dendritic cells and OK-432 for resectable pancreatic cancer patients

(2011) Hisahito Endo et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE